"The family physicians and providers in the Guthrie Tunkhannock, PA, office are dedicated to providing patients with the best in personalized services."

During the past decade, Robert Packer Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Robert Packer Hospital" #1 sponsor was "The Guthrie Clinic" with 10 trials, followed by "Pfizer" with 3 trials sponsored, "Anesiva, Inc." with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Abiomed Inc." with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robert Packer Hospital" #1 collaborator was "Johns Hopkins University" with 1 trials as a collaborator, "Medical University of South Carolina" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Robert Packer Hospital" are "Coronary Artery Disease" (2 trials), "Accidental Falls" (1 trials), "Acute Coronary Syndrome" (1 trials), "Ambulatory" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Robert Packer Hospital" in a lesser frequency.

Most popular intervention types in "Robert Packer Hospital" are "Drug" (10 trials), "Other" (8 trials), "Device" (5 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "CGT003 (E2F Duplex Decoy)" (2 trials), "2% Chlorhexidine Gluconate cloths" (1 trials), "Active Comparator (erlotinib)" (1 trials), "Barrier box" (1 trials) and "DES" (1 trials). Other intervention names were less common.

The vast majority of trials in "Robert Packer Hospital" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Robert Packer Hospital". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Robert Packer Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Robert Packer Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".